Morphine conditioned place preference is attenuated by perinatal lead exposure

Pharmacology Biochemistry and Behavior

Volumn 75, Issue 2, 2003, Pages 295-300

  Valles, Rodrigo ^a   Cardon, Aaron L ^a   Heard, Heather M ^a   Bratton, Gerald R ^b   Nation, Jack R ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Conditioned place preference; Developmental; Lead; Morphine

Indexed keywords

ACETIC ACID; LEAD; MORPHINE; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD; BODY WEIGHT; BREEDING; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EATING; FEEDING; FEMALE; INSTRUMENTAL CONDITIONING; LACTATION; LEAD BLOOD LEVEL; LEAD POISONING; MALE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PHYSIOLOGY; PLACE PREFERENCE; PREGNANCY; PRIORITY JOURNAL; RAT; RAT STRAIN; REINFORCEMENT; WEANING;

ANIMALIA;

EID: 0037770123     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00088-1     Document Type: Article

References (30)

1. Brown A.P., Dinger N., Levine B.S. Stress produced by gavage administration in the rat. Contemp. Top. Lab. Anim. Sci. 39:2000;17-21.
2. Calcagnetti D.J., Schechter M.D. Extinction of cocaine-induced place approach in rats: a validation of the biased procedure. Brain Res. Bull. 30:1993;695-700.
3. Cory-Slechta D.A. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Annu. Rev. Pharmacol. Toxicol. 35:1995;391-415.
4. 3 receptor antagonist sulpride on self-administration of morphine into the ventral tegmental area of the nucleus accumbens. Psychopharmacology. 160:2002;307-317.
5. Dearth R.K., Hiney J.K., Srivasta V.K., Burdick S.B., Bratton G.R., Dees W.L. Effects of lead (Pb) exposure during gestation and lactation on female pubertal development in the rat. Reprod. Toxicol. 16:2002;343-352.
6. Ensminger M.E., Anthony J.C., McCord J. The inner city and drug use: initial findings from an epidemiological study. Drug Alcohol Depend. 48:1997;175-184.
7. Godwin H.A. The biological chemistry of lead. Curr. Opin. Chem. Biol. 5:2001;223-227.
8. Harwell T.S., Spence M.R., Sands A., Iguchi M.Y. Substance use in an inner-city family planning population. J. Reprod. Med. 41:1996;704-710.
9. Hoffman D.C. The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res. Bull. 23:1989;373-387.
10. Holson R.R., Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol. Teratol. 14:1992;221-228.
11. Jeziorski M., White F.J. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur. J. Pharmacol. 275:1995;235-244.
12. Jeziorski M., White F.J., Wolf M.E. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse. 16:1994;137-147.
13. Kitchen I. Lead toxicity and alterations in opioid systems. Neurotoxicology. 14:1993;115-124.
14. Kitchen I., Kelly M. Effect of perinatal lead treatment on morphine-dependence in the adult-rat. Neurotoxicology. 14:1993;125-130.
15. Lasley S.M., Green M.C., Gilbert M.E. Rat hippocampal NMDA receptor binding as a function of chronic lead exposure level. Neurotoxicol. Teratol. 23:2001;185-189.
16. Lynch W.J., Carroll M.E. Regulation of drug intake. Exp. Clin. Psychopharmacol. 9:2001;131-143.
17. Manzanedo C., Serrano A., Aguilar M.A., Rodriguez-Arias M., Minarro J. Effects of CGS 10746B on hyperactivity and place preference induced by morphine. Behav. Brain Res. 126:2001;23-32.
18. Miller D.K., Nation J.R. Chronic cadmium exposure attenuates the reinforcing properties of morphine and fentanyl. Brain Res. 776:1997;162-169.
19. Miller D.K., Nation J.R., Bratton G.R. Perinatal exposure to lead attenuates the conditioned reinforcing properties of cocaine in male rats. Pharmacol. Biochem. Behav. 67:2000;111-119.
20. Miller D.K., Nation J.R., Jost T.E., Schell J.B., Bratton G.R. Differential effects of adult and perinatal lead exposure on morphine-induced locomotor activity in rats. Pharmacol. Biochem. Behav. 67:2000;281-290.
21. Miller D.K., Nation J.R., Bratton G.R. The effects of perinatal lead exposure to lead on the discriminative properties of cocaine and related drugs. Psychopharmacology. 158:2001;165-174.
22. Nation J.R., Livermore C.L., Burkey R.T. Chronic lead exposure attenuates sensitization to the locomotor-stimulating effects of cocaine. Drug Alcohol Depend. 41:1996;143-149.
23. Nation J.R., Miller D.K., Bratton G.R. Perinatal lead exposure alters the stimulatory properties of cocaine at PND 30 and PND 90 in the rat. Neuropsychopharmacology. 23:2000;444-454.
24. Nation J.R., Cardon A.L., Heard H.M., Valles R., Bratton G.R. Perinatal lead exposure and relapse to drug-seeking behavior in the rat: a cocaine reinforcement study. Psychopharmacology. 2003;. [in press].
25. Pirkle J.L., Brody D.J., Gunter E.W., Kramer R.A., Paschal D.C., Flegal T.D.et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). J. Am. Med. Assoc. 272:1994;284-291.
26. Pokora M.J., Richfield E.K., Cory-Slechta D.A. Preferential vulnerability of nucleus accumbens dopamine binding sites to low level lead-exposure: time course of effects and interactions with chronic dopamine agonist treatments. J. Neurochem. 67:1996;1540-1550.
27. Ranaldi R., Wise R.A. Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J. Neurosci. 21:2001;5841-5846.
28. Tavakoli-Nezhad M., Barron A.J., Pitts D.K. Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat. Neurotoxicology. 22:2001;259-269.
29. Vanderschuren L.J.M.J., Kalivas P.W. Alterations in dopaminergic and glutamate transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 151:2000;99-120.
30. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.